Sumitomo Dainippon Pharma Annual Report 2017
84/102

Derivative transactions as of March 31, 2016 were as follows:1) Currency related derivative transactions to which hedge accounting is not applied Transaction except market transactionContract amountsMillions of yenTransaction typeFair valueTotalPortion over1 year¥ 201¥ 201¥ 201¥ 201——¥ 15,692¥ 15,692USDTotalSell contractsForeign exchange forward contracts2) Currency related derivative transactions to which hedge accounting is applied Main items hedged by foreign forward exchange forward contracts are trade accounts payable.Notes to Consolidated Financial StatementsSumitomo Dainippon Pharma Co., Ltd. and Consolidated SubsidiariesYears Ended March 31, 2017 and 2016Financial SectionValuationdifferenceFair valueContract amountsMillions of yenTransaction typeFair valueTotalPortion over1 year¥ (22)2(0)¥ (20)————¥ 2,321481139¥ 2,941USDEURTHBTotalBuy contracts Foreign exchange forward contractsMillions of yenTransaction type——————————¥ 49155510¥ 561USDEURGBPTHBTotalBuy contracts Foreign exchange forward contractsThe following foreign exchange forward contracts meet certain conditions and their corresponding hedged items are stated at the forward exchange contract rates. Main items hedged by foreign exchange forward contracts are trade accounts payable, and their fair values are included in those of their hedged items in the notes of “5.Financial instruments”.Contract amountsFair valueTotalPortion over1 yearSumitomo Dainippon Pharma Co., Ltd. Annual Report 201783

元のページ  ../index.html#84

このブックを見る